Maxpro Capital Acquisition Corp. Cl A (JMAC): Price and Financial Metrics


Maxpro Capital Acquisition Corp. Cl A (JMAC): $10.18

-0.09 (-0.88%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

JMAC Stock Price Chart Interactive Chart >

Price chart for JMAC

JMAC Price/Volume Stats

Current price $10.18 52-week high $10.50
Prev. close $10.27 52-week low $9.87
Day low $10.18 Volume 3,700
Day high $10.22 Avg. volume 26,529
50-day MA $10.13 Dividend yield N/A
200-day MA $0.00 Market Cap 136.70M

Maxpro Capital Acquisition Corp. Cl A (JMAC) Company Bio


Maxpro Capital Acquisition Corp. operates as a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on June 2, 2021 and is headquartered in Taipei City, Taiwan.


JMAC Latest News Stream


Event/Time News Detail
Loading, please wait...

JMAC Latest Social Stream


Loading social stream, please wait...

View Full JMAC Social Stream

Latest JMAC News From Around the Web

Below are the latest news stories about MAXPRO CAPITAL ACQUISITION CORP that investors may wish to consider to help them evaluate JMAC as an investment opportunity.

Maxpro Capital Acquisition Corp. Confirms Additional Funding and Extension of Deadline to Complete Initial Business Combination

TAIPEI CITY, Oct. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) (the “Company”) announced today that its sponsor, MP One Investment LLC (the “Sponsor”), deposited an additional payment in the aggregate amount of $1,035,000 (representing $0.10 per public share) (the “Extension Payment”) into the Company’s trust account for its public stockholders. This deposit enables the Company to extend the date by which the Company has to complete its initial

Yahoo | October 14, 2022

Maxpro Capital Acquisition Corp. Announces Extension to Deadline to Complete Business Combination

Taipei City, Oct. 07, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) (the “Company”), announced today that its sponsor, MP One Investment LLC (the “Sponsor”), has requested that the Company extend the date by which the Company has to consummate a business combination from October 13, 2022 to January 13, 2023 (the “Extension”). The Extension is the first of two three-month extensions permitted under the Company’s governing documents. In connection wit

Yahoo | October 7, 2022

Apollomics Inc., a Late-Stage Clinical Biopharmaceutical Company to be Listed on Nasdaq Through Business Combination with Maxpro Capital Acquisition Corp.

– Transaction values Apollomics at pre-money equity value of $899 million– Apollomics is a late-stage clinical biopharmaceutical company developing innovative product candidates for large, unmet medical needs –Broad pipeline of drug candidates across multiple oncology programs; two lead clinical-stage candidates addressing a combined $11 billion non-small cell lung cancer (“NSCLC”) and acute myeloid leukemia (“AML”) market opportunity –Transaction proceeds to accelerate development of late-stage

Yahoo | September 14, 2022

Read More 'JMAC' Stories Here

JMAC Price Returns

1-mo 0.39%
3-mo 0.49%
6-mo 1.29%
1-year 2.83%
3-year N/A
5-year N/A
YTD N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.544 seconds.